menu
    • menu

    Company profile for Genocea

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Genocea’s mission is to help conquer cancer through targeted vaccines and immunotherapies. Two things make us unique: our team and our technology. Learn more about our team here. Learn more about our ATLAS™ platform, and the ways it may enable us to make differentiated cancer immunotherapies here. Our lead program, GEN-009, uses the ATLAS platform to optimize neoantigen selection for personalized cancer vaccines. We are cu...
    Genocea’s mission is to help conquer cancer through targeted vaccines and immunotherapies. Two things make us unique: our team and our technology. Learn more about our team here. Learn more about our ATLAS™ platform, and the ways it may enable us to make differentiated cancer immunotherapies here. Our lead program, GEN-009, uses the ATLAS platform to optimize neoantigen selection for personalized cancer vaccines. We are currently evaluating the safety, immunogenicity & efficacy of GEN-009 in a Phase 1/2a clinical trial. We are a publicly traded company listed on NASDAQ under the ticker symbol GNCA. Genocea is headquartered in Cambridge.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GenoceaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Acorn Park Dr Cambridge, MA 02140
    Telephone
    Telephone
    617.876.8191
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.genocea.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/genocea-biosciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/GenoceaBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genocea Closes Shop, Delists From NASDAQ
    Genocea Closes Shop, Delists From NASDAQ

    25 May 2022

    // V. Singh BENZINGA

    https://www.benzinga.com/general/biotech/22/05/27369427/genocea-closes-shop-delists-from-nasdaq

    V. Singh BENZINGA
    25 May 2022
    Share Share
    Genocea to cut 65% staff; Plans Strategic Alternatives
    Genocea to cut 65% staff; Plans Strategic Alternatives

    30 Apr 2022

    // YAHOO FINANCE

    https://finance.yahoo.com/news/genocea-initiates-restructuring-announces-plan-200500194.html

    YAHOO FINANCE
    30 Apr 2022
    Share Share
    Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR
    Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR

    08 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/08/2419473/36309/en/Genocea-Presents-Encouraging-Initial-Data-from-GEN-011-Phase-1-2a-Trial-at-AACR-2022.html

    GLOBENEWSWIRE
    08 Apr 2022
    Share Share
    Genocea Biosciences to Host Investor Webinar
    Genocea Biosciences to Host Investor Webinar

    04 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/04/2415701/36309/en/Genocea-Biosciences-to-Host-Investor-Webinar.html

    GLOBENEWSWIRE
    04 Apr 2022
    Share Share
    Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference
    Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference

    14 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/14/2402966/36309/en/Genocea-to-Present-at-the-32nd-Annual-Oppenheimer-Healthcare-Conference.html

    GLOBENEWSWIRE
    14 Mar 2022
    Share Share
    Genocea Provides Q4 2021 Corporate Update
    Genocea Provides Q4 2021 Corporate Update

    10 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/10/2400738/36309/en/Genocea-Provides-Fourth-Quarter-2021-Corporate-Update.html

    GLOBENEWSWIRE
    10 Mar 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search